Litcius/Paper detail

Wegovy: FDA approves weight loss drug to cut cardiovascular risk

Janice Hopkins Tanne

2024BMJ12 citationsDOI

Topics & Concepts

Weight lossMedicineDrugPharmacologyComputer scienceInternal medicineObesityPharmacology and Obesity TreatmentDiet and metabolism studiesDiabetes Treatment and Management
Wegovy: FDA approves weight loss drug to cut cardiovascular risk | Litcius